Evidence map›Paper›PMID 34733120›Full record

ArticleJournal of machine learning research : JMLR2021

Estimation and Optimization of Composite Outcomes.

Daniel J Luckett, Eric B Laber, Siyeon Kim, Michael R Kosorok

Abstract read
In one paragraph

Article in Journal of machine learning research : JMLR, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Fusing Individualized Treatment Rules Using Secondary Outcomes.Proceedings of machine learning research · 2024
    Article
  6. Article
  7. Article
  8. Precision Medicine.Annual review of statistics and its application · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Daniel J LuckettGenospace, Boston, MA 02108, USA.
Eric B LaberDepartment of Statistics, North Carolina State University, Raleigh, NC 27607, USA.
Siyeon KimDepartment of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27607, USA.
Michael R KosorokDepartments of Biostatistics and Statistics & Operations Research, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Funding

Statistical Methods for Cancer Clinical TrialsP01CA142538 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KOSOROK, MICHAEL R · 2010 to 2019
$21.3M
Statistical methods for healthcare in complex patients with diabetesR01DK108073 · NIDDK · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ZHAO, YINGQI · 2015 to 2019
$1.5M
NCI NIH HHS P01 CA142538NIDDK NIH HHS R01 DK108073
6 · The paper itself

Abstract

There is tremendous interest in precision medicine as a means to improve patient outcomes by tailoring treatment to individual characteristics. An individualized treatment rule formalizes precision medicine as a map from patient information to a recommended treatment. A treatment rule is defined to be optimal if it maximizes the mean of a scalar outcome in a population of interest, e.g., symptom reduction. However, clinical and intervention scientists often seek to balance multiple and possibly competing outcomes, e.g., symptom reduction and the risk of an adverse event. One approach to precision medicine in this setting is to elicit a composite outcome which balances all competing outcomes; unfortunately, eliciting a composite outcome directly from patients is difficult without a high-quality instrument, and an expert-derived composite outcome may not account for heterogeneity in patient preferences. We propose a new paradigm for the study of precision medicine using observational data that relies solely on the assumption that clinicians are approximately (i.e., imperfectly) making decisions to maximize individual patient utility. Estimated composite outcomes are subsequently used to construct an estimator of an individualized treatment rule which maximizes the mean of patient-specific composite outcomes. The estimated composite outcomes and estimated optimal individualized treatment rule provide new insights into patient preference heterogeneity, clinician behavior, and the value of precision medicine in a given domain. We derive inference procedures for the proposed estimators under mild conditions and demonstrate their finite sample performance through a suite of simulation experiments and an illustrative application to data from a study of bipolar depression.

Indexed as

Individualized treatment rulesInverse reinforcement learningPrecision medicineUtility functions

Identifiers

PMID34733120
PMCPMC8562677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.